Completed PHASE2/PHASE3 INTERVENTIONAL 15-arm NCT00935350

Reduction of the Glycemic Index by a Novel Viscous Polysaccharide

Effect of Adding the Novel Fiber, PGX®,to Commonly Consumed Foods on Glycemic Response and Glycemic Index: A Practical and Effective Strategy for Reducing Post Prandial Blood Glucose Levels.

Sponsor: Canadian Center for Functional Medicine

Conditions Blood Glucose, Postprandial

Interventions PolyGlycopleX (PGX)

Updated 5 times since 2017 Last updated: Jul 8, 2009 Started: May 31, 2006 Primary completion: Jun 30, 2006 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Blood Glucose, Postprandial, this trial is completed. The trial is conducted by Canadian Center for Functional Medicine and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Center for Functional Medicine
Glycemic Index Laboratories, Inc
InovoBiologic Inc.

Data source: Glycemic Index Laboratories, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada